drugset / Trial / NCT00246584
A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the safety and efficacy of long term treatment of SPP100 in patients with essential hypertension. (Trial is not recruiting in the US)
Timeline
- Start
- 2004-10
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aliskiren | Small molecule | — | — |